Galecteye Pharma ApS: Financial statements 2020
CVR: 38248243
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Galecteye Pharma ApS (CVR 38248243) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -6,250 and a net result of DKK -7,280 compared with DKK -6,020 the year before. Equity in the 2020 report amounted to DKK 7,497. The solvency ratio was 6.4%.
- Gross Profit
- DKK -6,250
- Profit/Loss
- DKK -7,280
- Equity
- DKK 7,497
- Total Assets
- DKK 117,849
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | -6 t. | -7 t. | 7 t. | - |
| 2019 | - | -5 t. | -6 t. | 15 t. | - |
| 2018 | - | -10 t. | -11 t. | 21 t. | - |
| 2017 | - | -17 t. | -18 t. | 32 t. | - |
How creditworthy is Galecteye Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Galecteye Pharma ApS has published its annual report for 2019. Gross profit came to DKK -5,000, and the net result was DKK -6,020.
About Galecteye Pharma ApS
Galecteye Pharma ApS was a Danish company of the type Anpartsselskab based in København N, founded in 2016 and dissolved in 2022. The company was registered under the industry Fremstilling af farmaceutiske præparater. In 2020, the company reported a gross profit of DKK -6,250 and a net result of DKK -7,280 compared with DKK -6,020 the year before. Equity in the 2020 report amounted to DKK 7,497.